Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meghan Barnes

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|April 28, 2022
Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United StatesKristina L Bajema, Ryan Gierke, Monica M Farley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2019
Early Impact of 13-Valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease Among Adults With and Without Underlying Medical Conditions-United StatesSana S Ahmed, Tracy Pondo, Wei Xing, et al.
MMWR. Morbidity and Mortality Weekly Report|April 13, 2023
Secondary Cases of Invasive Disease Caused by Encapsulated and Nontypeable Haemophilus influenzae - 10 U.S. Jurisdictions, 2011-2018Sara E Oliver, Amy B Rubis, Heidi M Soeters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2023
Epidemiology of Invasive Nontypeable Haemophilus influenzae Disease-United States, 2008-2019Sara E Oliver, Amy B Rubis, Heidi M Soeters, et al.
The Pediatric Infectious Disease Journal|January 21, 2025
Characteristics of Invasive Pneumococcal Diseases Cases Among U.S. Children With Hematologic Malignancies Before and After Introduction of Thirteen-valent Pneumococcal Conjugate Vaccine, 2005-2019Katie Hamilton, Ulzii-Orshikh Luvsansharav, Wei Xing, et al.
Pediatrics|February 15, 2020
Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001-2016Tolulope A Adebanjo, Tracy Pondo, David Yankey, et al.
Pediatrics|January 18, 2012
Pertussis Pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA From clinic surfacesSema Mandal, Kathleen M Tatti, Denise Woods-Stout, et al.
Vaccine|May 4, 2024
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort studyKristin L Andrejko, Ryan Gierke, Jemma V Rowlands, et al.
The Lancet. Respiratory Medicine|March 19, 2016
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control studyMatthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
The Lancet. Infectious Diseases|December 21, 2019
Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort studyKevin Messacar, Emily Spence-Davizon, Christina Osborne, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|April 28, 2022
Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United StatesKristina L Bajema, Ryan Gierke, Monica M Farley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2019
Early Impact of 13-Valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease Among Adults With and Without Underlying Medical Conditions-United StatesSana S Ahmed, Tracy Pondo, Wei Xing, et al.
MMWR. Morbidity and Mortality Weekly Report|April 13, 2023
Secondary Cases of Invasive Disease Caused by Encapsulated and Nontypeable Haemophilus influenzae - 10 U.S. Jurisdictions, 2011-2018Sara E Oliver, Amy B Rubis, Heidi M Soeters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2023
Epidemiology of Invasive Nontypeable Haemophilus influenzae Disease-United States, 2008-2019Sara E Oliver, Amy B Rubis, Heidi M Soeters, et al.
The Pediatric Infectious Disease Journal|January 21, 2025
Characteristics of Invasive Pneumococcal Diseases Cases Among U.S. Children With Hematologic Malignancies Before and After Introduction of Thirteen-valent Pneumococcal Conjugate Vaccine, 2005-2019Katie Hamilton, Ulzii-Orshikh Luvsansharav, Wei Xing, et al.
Pediatrics|February 15, 2020
Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001-2016Tolulope A Adebanjo, Tracy Pondo, David Yankey, et al.
Pediatrics|January 18, 2012
Pertussis Pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA From clinic surfacesSema Mandal, Kathleen M Tatti, Denise Woods-Stout, et al.
Vaccine|May 4, 2024
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort studyKristin L Andrejko, Ryan Gierke, Jemma V Rowlands, et al.
The Lancet. Respiratory Medicine|March 19, 2016
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control studyMatthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
The Lancet. Infectious Diseases|December 21, 2019
Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort studyKevin Messacar, Emily Spence-Davizon, Christina Osborne, et al.
Pageof 3